Wigzell Hans Lennart Rudolf

Wigzell Hans Lennart Rudolf is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT). The current snapshot covers public activity from Dec 16, 2024 to Jun 5, 2026. Reported amounts are shown as $477.7K to $144.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.